Scleroderma and scleroderma-like syndromes

18Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

Systemic sclerosis is a systemic connective tissue disease whose main pathophysiological mechanism is a progressive fibrosis of internal organs and skin leading to thickening and induration. Blood vessels may also be involved. However, systemic scleroderma is not the only disease causing cutaneous sclerosis. There is a group of diseases that mimic scleroderma in their clinical presentation - these are scleroderma-like syndromes. A distinction can be made between syndromes of inflammatory/autoimmune, genetic, metabolic, toxic, drug-induced, occupational, paraneoplastic and syndromes caused by deposition disorders. In the following paper, we have reviewed the literature on scleroderma-like syndromes. We have outlined the factors predisposing to the development of each disease, its pathogenesis, clinical presentation, diagnostic and treatment process and the differences between each syndrome and systemic scleroderma.

Cite

CITATION STYLE

APA

Romanowska-Próchnicka, K., Dziewit, M., Lesiak, A., Reich, A., & Olesińska, M. (2024). Scleroderma and scleroderma-like syndromes. Frontiers in Immunology. Frontiers Media SA. https://doi.org/10.3389/fimmu.2024.1351675

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free